Our Compounds

Retatrutide is an advanced metabolic peptide currently under clinical development. As a triple agonist, it activates three key hormone pathways — GLP-1, GIP, and glucagon receptors — creating a powerful metabolic effect that supports significant fat loss, improved glycemic control, and potential muscle preservation.

By simultaneously targeting these pathways, Retatrutide helps reduce appetite, increase energy expenditure, and enhance insulin sensitivity. This multi-mechanism approach may produce a stronger metabolic response than single-pathway therapies.

In clinical trials, participants have reported weight reductions exceeding 20% within a year, highlighting Retatrutide as one of the most promising next-generation metabolic peptides under investigation.

Due to its ability to influence energy balance, fat metabolism, and glucose regulation, Retatrutide is gaining attention for its potential role in advanced metabolic treatment and body-composition optimization.

GHK-Cu is a naturally occurring copper-binding peptide recognized for its powerful regenerative and tissue-repair properties. Widely studied in regenerative and cosmetic research, this peptide plays a key role in stimulating collagen production, supporting skin remodeling, and enhancing overall skin elasticity.

GHK-Cu has also been shown to accelerate wound healing, reduce inflammation, and support cellular repair processes, making it a compound of interest in both dermatological and recovery-focused research.

In addition to its skin benefits, emerging research suggests GHK-Cu may help support hair follicle health and promote hair regrowth, while its influence on tissue regeneration and anti-inflammatory pathways may contribute to improved recovery and muscle repair at the cellular level.

Because of its broad regenerative potential, GHK-Cu has become a highly regarded peptide in longevity, skin health, and performance recovery research.